CIK 0001420565 · Non-accelerated filer<br>Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 134196017
- Phone
- 7378021989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-24 | Novartis Bioventures Ltd 10% owner | Sale | −700 | $4.11 | $3K | 2,500,082 |
| 2018-07-23 | Novartis Bioventures Ltd 10% owner | Sale | −30,600 | $4.25 | $130K | 2,500,782 |
| 2018-07-17 | Novartis Bioventures Ltd 10% owner | Sale | −12,500 | $4.71 | $59K | 2,531,382 |
| 2018-07-16 | Novartis Bioventures Ltd 10% owner | Sale | −300 | $5.15 | $2K | 2,543,882 |
| 2017-07-05 | Novartis Bioventures Ltd 10% owner | Conversion | +2,277,515 | 2,277,515 | ||
| 2017-07-05 | Novartis Bioventures Ltd 10% owner | Purchase | +266,667 | $15.00 | $4.0M | 2,544,182 |
| 2017-07-05 | Novartis Bioventures Ltd 10% owner | Conversion · Series C Preferred Stock | −2,967,025 | 0 | ||
| 2017-07-05 | Novartis Bioventures Ltd 10% owner | Conversion · Series C-2 Preferred Stock | −4,238,607 | 0 | ||
| 2017-07-05 | Novartis Bioventures Ltd 10% owner | Conversion · Series D Preferred Stock | −6,781,770 | 0 | ||
| 2017-07-05 | Novartis Bioventures Ltd 10% owner | Conversion · Series E-2 Preferred Stock | −2,644,558 | 0 | ||
| 2017-07-05 | Novartis Bioventures Ltd 10% owner | Conversion · Series E-3 Preferred Stock | −2,293,829 | 0 | ||
| 2017-07-05 | Novartis Bioventures Ltd 10% owner | Conversion · Series F Preferred Stock | −3,705,882 | 0 |
Page 10 of 10 · 192 trades